Literature DB >> 8250682

The validity of DSM-III-R hypochondriasis.

R Noyes1, R G Kathol, M M Fisher, B M Phillips, M T Suelzer, C S Holt.   

Abstract

BACKGROUND: Because of the uncertainty about the status of hypochondriasis, the disorder is rarely diagnosed. To address this problem we examined the validity of DSM-III-R hypochondriasis as identified by structured interview.
METHODS: Patients in a general medicine clinic were screened for hypochondriacal attitudes and symptoms. Those patients who scored above an established cutoff had a structured diagnostic interview, and 50 patients who met DSM-III-R criteria for hypochondriasis and 50 age- and sex-matched controls were thus identified. Information was obtained from both groups on health perceptions, health care utilization, and level of functioning using self-report and physician-rated measures. Additional information on diagnoses and treatment recommendations was obtained from record audits.
RESULTS: Clinic physicians rated hypochondriacal subjects as having more unrealistic fear of illness (hypochondriasis) and diagnosed psychiatric and functional somatic syndromes more frequently in hypochondriacal than in control subjects. Hypochondriacal subjects viewed their health as worse, had more health worries, and had more severe psychiatric symptoms than control subjects. They also reported poorer physical functioning and work performance, greater health care utilization, poorer response to medical treatment, and less satisfaction with the care received than controls.
CONCLUSIONS: Results show that, although the diagnosis of hypochondriasis is rarely made, physician recognition is high. They also show that several indicators of internal and external validity of this diagnostic category exist. Findings suggest that if physicians are to reduce the functional impairment and nonproductive health care utilization of these patients, they will need to make the diagnosis of hypochondriasis and intervene appropriately. However, for this to occur, research demonstrating predictive validity and treatment responsiveness of the disorder will be required.

Entities:  

Mesh:

Year:  1993        PMID: 8250682     DOI: 10.1001/archpsyc.1993.01820240045006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  7 in total

1.  Effects of continuity of care and patient dispositional factors on the physician-patient relationship.

Authors:  Russell Noyes; Oladipo A Kukoyi; Susan L Longley; Douglas R Langbehn; Scott P Stuart
Journal:  Ann Clin Psychiatry       Date:  2011-08       Impact factor: 1.567

2.  A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis.

Authors:  Brian A Fallon; David K Ahern; Martina Pavlicova; Iordan Slavov; Natalia Skritskya; Arthur J Barsky
Journal:  Am J Psychiatry       Date:  2017-06-29       Impact factor: 18.112

Review 3.  Epidemiology and treatment of hypochondriasis.

Authors:  Mónica Magariños; Uzma Zafar; Kore Nissenson; Carlos Blanco
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Evaluation of a brief psychosocial intervention for health anxiety delivered by medical assistants in primary care: Study protocol for a pilot hybrid trial.

Authors:  Robert E Brady; Mark T Hegel; Geoffrey M Curran; Gordon J G Asmundson; Haiyi Xie; Martha L Bruce
Journal:  Contemp Clin Trials       Date:  2021-10-07       Impact factor: 2.226

5.  Sudden gains in internet-based cognitive behaviour therapy for severe health anxiety.

Authors:  Erik Hedman; Mats Lekander; Brjánn Ljótsson; Nils Lindefors; Christian Rück; Stefan G Hofmann; Erik Andersson; Gerhard Andersson; Stefan M Schulz
Journal:  Behav Res Ther       Date:  2014-01-11

6.  The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health.

Authors:  Per Fink; Eva Ørnbøl; Kaj Sparle Christensen
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

7.  Personality change following internet-based cognitive behavior therapy for severe health anxiety.

Authors:  Erik Hedman; Gerhard Andersson; Nils Lindefors; Petter Gustavsson; Mats Lekander; Christian Rück; Erik Andersson; Brjánn Ljótsson
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.